Short-term Prognostic Value of Lipid Measurements in Patients with Angina pectoris

Published on Jan 1, 2000in Thrombosis and Haemostasis4.733
· DOI :10.1055/s-0037-1614155
Ignasi Bolibar3
Estimated H-index: 3
A. von Eckardstein73
Estimated H-index: 73
+ 1 AuthorsSimon G. Thompson102
Estimated H-index: 102
We studied the role of various markers of lipid metabolism, hemostasis and inflammation in a two year follow-up of 3000 patients with angina pectoris, during which time 106 patients experienced myocardial infarction or sudden coronary death. Low levels of high density lipoprotein (HDL) cholesterol and of apolipoprotein (apo) A-I were most strongly associated with increased coronary risk. The relative risk per standard deviation increase was 0.68 for HDL cholesterol (95% confidence interval 0.55 to 0.84) and 0.66 for apoA-I (0.54 to 0.81). These associations were independent of other coronary risk factors, other lipid measurements, hemostatic factors, and C-reactive protein (CRP). The associations of total and LDL cholesterol, triglycerides, apoB, and lipoprotein( a) with coronary events were not independent of HDL cholesterol or hemostatic factors. We conclude that HDL cholesterol or apoA-I, hemostatic risk factors, and CRP are important prognostic markers of coronary events in secondary prevention.
  • References (0)
  • Citations (51)
📖 Papers frequently viewed together
1,518 Citations
1,346 Citations
588 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
Cited By51
Abstract Atherosclerosis remains the leading cause of ischemic syndromes such as myocardial infarction or brain stroke, mainly promoted by plaque rupture and subsequent arterial blockade. Identification of vulnerable or high-risk plaques constitutes a major challenge, being necessary to identify patients at risk of occlusive events in order to provide them with appropriate therapies. Clinical imaging tools have allowed the identification of certain structural indicators of prone-rupture plaques,...
#1Kuen-Ming Wu (Jen-Ai Hospital)H-Index: 1
#2Yuan-Man Hsu (PRC: China Medical University (PRC))H-Index: 19
Last. Chih Yang Huang (PRC: China Medical University (PRC))H-Index: 40
view all 13 authors...
High levels circulating saturated fatty acids are associated with diabetes, obesity and hyperlipidemia. In heart, the accumulation of saturated fatty acids has been determined to play a role in the development of heart failure and diabetic cardiomyopathy. High-density lipoprotein (HDL) has been reported to possess key atheroprotective biological properties, including cellular cholesterol efflux capacity, anti-oxidative and anti-inflammatory activities. However, the underlying mechanisms are stil...
2 CitationsSource
#1Diuli A. Cardoso (UFRJ: Federal University of Rio de Janeiro)H-Index: 1
#2Annie Seixas Bello Moreira (UERJ: Rio de Janeiro State University)H-Index: 7
Last. Glorimar Rosa (UFRJ: Federal University of Rio de Janeiro)H-Index: 9
view all 5 authors...
Introduction: saturated fat restriction has been recommended for coronary arterial disease, but the role of coconut oil (Cocos nucifera L.) extra virgin, lauric acid source in the management of lipid profile remains unclear. Objective: to evaluate the effect of nutritional treatment associated with the consumption of extra virgin coconut oil in anthropometric parameters and lipid profile. Methods: we conducted a longitudinal study of 116 adults of both sexes presenting CAD. Patients were followe...
19 CitationsSource
#1Molly A. Hall (PSU: Pennsylvania State University)H-Index: 10
#2Anurag Verma (PSU: Pennsylvania State University)H-Index: 10
Last. Sarah A. Pendergrass (PSU: Pennsylvania State University)H-Index: 28
view all 17 authors...
We performed a Phenome-wide association study (PheWAS) utilizing diverse genotypic and phenotypic data existing across multiple populations in the National Health and Nutrition Examination Surveys (NHANES), conducted by the Centers for Disease Control and Prevention (CDC), and accessed by the Epidemiological Architecture for Genes Linked to Environment (EAGLE) study. We calculated comprehensive tests of association in Genetic NHANES using 80 SNPs and 1,008 phenotypes (grouped into 184 phenotype ...
39 CitationsSource
#1Pascale M. Ohnsorg (UZH: University of Zurich)H-Index: 4
#2Jean-Luc Mary (Hoffmann-La Roche)H-Index: 10
Last. A. von Eckardstein (UZH: University of Zurich)H-Index: 73
view all 6 authors...
Abstract Apolipoprotein A-I (apoA-I) exerts many potentially anti-atherogenic properties and is therefore attractive for prevention and therapy of coronary heart disease. Since induction of apoA-I production by small molecules has turned out as difficult, application of exogenous apoA-I is pursued as an alternative therapeutic option. To counteract fast renal filtration of apoA-I, a trimeric high-molecular weight variant of apoA-I (TripA) was produced by recombinant technology. We compared TripA...
12 CitationsSource
Reducing cholesterol with statins has been clearly shown to reduce the risk of cardiovascular disease, but despite statin therapy there remains a considerable residual risk of cardiovascular disease. This article reviews the evidence supporting the management of lipids beyond cholesterol reduction with statin therapy alone.
2 CitationsSource
#1Stephen J. NichollsH-Index: 63
#2Wai Hong TangH-Index: 74
Last. Stanley L. HazenH-Index: 75
view all 7 authors...
For more than a century, evidence has continued to accumulate supporting the pivotal role of cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (CVD). The finding of a curvilinear relationship between systemic levels of LDL cholesterol (LDL-C) and prospective cardiovascular risk in population studies (1) and unequivocal clinical benefit of therapies that lower LDL-C (2) have prompted its central role in the approach to risk prediction and preventive strategies. However, th...
48 CitationsSource
Owing to many potentially anti-atherogenic functions and the inverse correlation of high-density lipoprotein (HDL)-cholesterol (C) plasma levels with cardiovascular risk, HDLs have evolved as an attractive target for the prevention and therapy of coronary heart disease. Previously, the failure of torcetrapib, the frequent confounding of low HDL-C with other pro-atherogenic conditions, as well as inconsistent data from patients and animal models with genetic HDL dyslipidemias, left in doubt the s...
25 CitationsSource
#1Harry HemingwayH-Index: 58
#2Martin HenrikssonH-Index: 17
Last. Mark SculpherH-Index: 75
view all 17 authors...
OBJECTIVE: To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with ...
35 CitationsSource
Purpose of reviewTo address the progress of the investigation on dysfunctional high-density lipoprotein (HDL).Recent findingsHDL is generally considered to be an independent protective factor against cardiovascular disease. However, emerging evidence indicates that HDL can be modified under certain
39 CitationsSource